Investors / Media

Webcast ImageWebcast
Infinity Pharmaceuticals, Inc. at BIO Investor Forum (Replay)
10/17/17 at 10:45 a.m. PT
Infinity Pharmaceuticals, Inc. at BIO Investor Forum
Tuesday, October 17, 2017 10:45 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways.

Stock Chart

More »
Stock chart for: INFI.O.  Currently trading at $2.40 with a 52 week high of $3.84 and a 52 week low of $0.84.

Recent Events

View all events »
Infinity Pharmaceuticals, Inc. at BIO Investor Forum
Oct 17, 2017 10:45 a.m. PT
Q2 2017 Infinity Pharmaceuticals, Inc. Earnings Conference Call
Aug 03, 2017 4:30 p.m. ET
Infinity Pharmaceuticals, Inc. at Precision Lung Cancer Conference
Jul 25, 2017 10:00 a.m. ET

Recent Releases

More >>
Infinity Announces IPI-549 Late-Breaking Presentation at SITC Annual Meeting
Oct 12, 2017
- Clinical and Translational Data from Monotherapy Dose-Escalation Component of Ongoing Phase 1/1b Study of IPI-549 in Patients with Advanced Solid Tumors to be Reported During an Oral Session - CAMBRIDGE, Mass., Oct. 12, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that an abstract describing new data for IPI-549, an orally administered immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma), has b... 
Infinity To Present At The 2017 BIO Investor Forum
Oct 10, 2017
CAMBRIDGE, Mass., Oct. 10, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 2017 BIO Investor Forum on Tuesday, October 17, 2017, at 10:45 a.m. PT (1:45 p.m. ET) in San Francisco, CA. A live webcast of Infinity's presentation will be accessible on the Investors/Media section of Infinity's website at, and will be available for 30 days following the event. About Infinity Infinity is an innovative biopharmaceutical company dedicated to ad... 
Infinity Pharmaceuticals and Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 in Combination with Opdivo (Nivolumab)
Sep 25, 2017
- Collaboration Expands Ongoing Phase 1/1b Study to Include Patients with Triple Negative Breast Cancer Who Have Not Been Previously Exposed to Anti-PD-1 or Anti-PD-L1 Therapy - CAMBRIDGE, Mass., Sept. 25, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has expanded its existing clinical collaboration with Bristol-Myers Squibb evaluating IPI-549 in combination with Opdivo® to include patients with triple negative breast cancer (TNBC) who have not b... 

INFI (Common Stock)

Change: + 0.30 (14.29%)
Intraday High:$2.62
Intraday Low:$2.10
Oct 19, 2017 at 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Annual Report

2016 Annual Report
Data Provided by Thomson Reuters